Publications and Presentations

Publications 

Presentations

2018

  • Inaugural Clinical Registries Summit, SPHPM, Monash, November 2018

A. Spencer. The Myeloma and Related Diseases Registry
N. Aoki, E. Moore. The APAC MRDR and other MRDR International Collaborations

  • Blood 2018, October, Brisbane

A. Spencer et al., MRDR Interest Group breakfast meeting
Z. McQuilten et al., Predictors of early mortality in multiple myeloma: Results from the ANZ MRDR
K. Bergin et al., The MRDR: the first five years - the myeloma landscape in ANZ (Nominated for HSANZ Outstanding Young Investigator Award)
E. Moore et al., Health-related quality of life at diagnosis in multiple myeloma: EQ-5D-5L results from the MRDR and comparison with an Australian population norm (Poster - Awarded Snowdome Foundation Haematology Nurse Myeloma Travel grant: $2500)

  • 2nd National Myeloma Workshop, Yarra Valley, Australia, September 2018

- E. Moore et al., Health-related quality of life at diagnosis in multiple myeloma: EQ-5D-5L results from the Myeloma and Related Diseases Registry (Poster)
- Z. McQuilten et al., Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (Poster)

  • A. Spencer. Real world outcomes from the Myeloma and Related Diseases Registry. 3rd Annual Educational Seminar, Myeloma Special Practice Network, HSANZ Nurses Group, Royal Adelaide Hospital: August 2018
  • E. Moore. News from the Myeloma and Related Diseases Registry. Registry Special Interest Group meeting, SPHPM, Monash: July 2018
  • E. Moore and T. King, Growth and outcomes of the Myeloma and Related Diseases Registry. Quality of Life Office meeting, University of Sydney, July 2018
  • E. Moore et al., Maturing data from the Australia and New Zealand Myeloma and Related Diseases Registry (Poster), Alfred week, The Alfred Hospital, June 2018
  • K. Bergin et al., Utilisation Rates of Upfront Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma:  a report on behalf of the MRDR (Poster), EBMT, Lisbon, March 2018

2017

Talks including reference to or introduction of the MRDR:

  • H. Blacklock/T. King, National Haematology Nurses meeting, September 2017

2016

Talks including reference to or introduction of the MRDR:

  • S. Gibbs, Myeloma lectures, Royal Darwin Hospital, Aug 2016

2015

Talks including reference to or introduction of the MRDR:

  • A. Kalff, Binding site Educational Workshop, Melbourne, November, 2015
  • A. Kalff, Myeloma Australia, Medical scientific advisory group (MSAG) meeting, Melbourne, November, 2015
  • T. King, Update from IMW 2015 Rome: Nursing Symposium. HSANZ NG NSW Dinner Meeting. Sydney, November 2015 (poster)
  • T. King, Best practice in the administration of chemotherapy: Bortezomib focus. Tata Memorial Hspt Mumbai; Cancer Institute Chennai; Apollo Hospital Chennai; All India Institute of Medical Sciences (AIMS) Delhi; Rajiv Gandhi Cancer Institute Delhi India, August, 2015
  • A. Kalff, Myeloma Australia, medical scientific advisory group (MSAG) meeting, Melbourne, May, 2015

2014

  • A. Spencer, Myeloma Scientific Advisory Group, Myeloma Foundation Australia, Melbourne, Victoria
  • A. Spencer, MRDR Interest Group Meeting, HAA, Perth, Western Australia, October 2014

Talks including reference to or introduction of the MRDR:

  • T. King, The Clinical Care of Multiple Myeloma Patients with Targeted Therapy. Taipei, Taiwan, November 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients with Targeted Therapy. Kaohsiung, Taiwan, November 2014
  • T. King, Making sense of myeloma: An overview of treatment. Leukaemia and Blood Cancer Foundation & HSANZ Nurses Group Educational meeting for nurses, September 2014 
  • T. King, Myeloma: An overview of disease, treatments and management of side effects. Leukaemia and Blood Cancer Foundation Patient and Family Forum Auckland New Zealand, September 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients. The First Affiliated Hospital of College of Medicine Zhejiiang University. Hangzhou, China, February 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients. Shanghai Changzheng, Shanghaim, China, February 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients. Institute of Haematology and Blood Diseases Hospital Chinese Academy of Medical Sciences. Tianjin, China, February 2014

2013

  • A. Spencer HAA Investigator Meeting, Gold Coast, Queensland